Risk assess16 Dec 2020 09:54
BC and GDR have obviously sat down and said, we have waited far too long, like all investors here, can we bypass. Yip as per previous posters had said and DB confirmed at presentation. He has stuck to his word.
Now what is the risks of by passing, very little as every test may have a % of false positives. Why was it not done sooner, as BC collab was being worked on. Which I’m guessing by that RNS, it states the biomerk has proven the effectiveness. So now was the time. Let me repeat
NOW IS THE TIME!
What do we need sales wise to get SP back to £1, I’d guess between £7 to £10 mill sale.